Market Capitalization (Millions $) |
10,305 |
Shares
Outstanding (Millions) |
182 |
Employees |
19,000 |
Revenues (TTM) (Millions $) |
4,098 |
Net Income (TTM) (Millions $) |
-1,302 |
Cash Flow (TTM) (Millions $) |
-213 |
Capital Exp. (TTM) (Millions $) |
437 |
Catalent Inc
Catalent Inc. is a leading provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It was founded in 2007 and is headquartered in Somerset, New Jersey, United States. Catalent has a global presence with more than 35 sites across North America, Europe, and Asia-Pacific regions.
The company offers a wide array of services, including drug development, clinical trial solutions, analytical testing, drug delivery technologies, and manufacturing solutions. Catalent specializes in creating innovative technologies that enhance drug delivery, bioavailability, and therapeutic performance, making it possible to efficiently develop and bring life-changing treatments to market.
Catalent deals with a broad range of pharmaceutical clients that rely on them for customized solutions to their unique drug development requirements, with a focus on quality, efficiency, and speed. Their clients include leading pharmaceutical companies, biotech firms, and small to mid-sized pharmaceutical companies that seek end-to-end drug development services.
The company operates under four business segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment develops and manufactures a wide range of solid and semi-solid dose forms of drugs, including softgels, capsules, and tablets. The Biologics segment offers gene therapy, biomanufacturing, and drug development services to biotechnology companies.
The Oral and Specialty Delivery segment is responsible for developing delivery technologies that can enhance oral dosage form efficacy, stability, and performance. This segment produces OptiDose drug delivery systems, which blend drug and excipients into uniform granules that can be compressed into tablets. The Clinical Supply Services segment is responsible for ensuring global clinical trial supply chains operate efficiently to ensure safe and efficient delivery of drugs and therapies.
Catalent is committed to sustainability and environmentally responsible practices in all its operations. It partners with clients to implement greener manufacturing processes using eco-friendly materials and technologies that reduce energy consumption and enable waste reduction. The company has numerous partnerships with academic institutions and leading industry organizations to improve global health outcomes.
In conclusion, Catalent Inc. is a leading player in the drug development and manufacturing industry, offering advanced delivery technologies, development, and analytical testing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It has a highly skilled and experienced team of experts, a global footprint and a commitment to sustainability and green manufacturing processes.
Company Address: 14 Schoolhouse Road Somerset, 8873 NJ
Company Phone Number: 537-6200 Stock Exchange / Ticker: NYSE CTLT
|